Your search history is turned on.
Date: April 16, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
DIAGNOS acclrera la demande de licence d'instrument mdical Sant Canada et la FDA des tats-Unis concernant ses 4 nouveaux modules d'analyse, et prvoit la certification ISO 27001 16/04/2024 DIAGNOS acclrera la demande de licence d'instrument mdical Sant Canada et la FDA des tats-Unis concernant ses 4 nouveaux modules d'analyse, et prvoit ...
DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification 2024.04.16 DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification ...
Date: April 9, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
DIAGNOS inc. prsentera la confrence des investisseurs hybrides AI & Technologie le 11 avril 09/04/2024 DIAGNOS inc. prsentera la confrence des investisseurs hybrides AI & Technologie le 11 avril Montral Canada, le 9 avril 2024 DIAGNOS inc. (ADK TSX : OTCQB : DGNOF)), base Montral, au Canada, spcialise dans l'intelligence artificielle...
DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th 2024.04.09 DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence for the medical market, today a...
Date: April 3, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
DIAGNOS annonce un octroi d'options d'achat d'actions 03/04/2024 DIAGNOS annonce un octroi d'options d'achat d'actions BROSSARD, Qubec, Canada le 3 avril 2024 - Diagnos inc. ( DIAGNOS ou la Socit ) (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier dans le dpistage prcoce de problmes graves de sant grce lintelligence art...
DIAGNOS Announces Grant of Stock Options 2024.04.03 DIAGNOS Announces Grant of Stock Options BROSSARD, Quebec, Canada April 3, 2024 - Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces today a grant...
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
DIAGNOS souhaite la bienvenue au Dr Philippe Couillard au sein de son conseil d'administration 02/04/2024 DIAGNOS souhaite la bienvenue au Dr Philippe Couillard au sein de son conseil d'administration Brossard, Qubec, Canada le 2 avril 2024 Diagnos inc. ( DIAGNOS ou la Socit ) (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier...
DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors 2024.04.02 DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors Brossard, Quebec, Canada April 2, 2024 - Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intell...
Date: March 28, 2024 Jurisdictions: Ontario, Quebec
Crer la dclaration de placement avec dispense (Annexe 45-106A1) Annexe 45- 106A1 Dclaration de placement avec dispense RUBRIQUE 1 - TYPE DE DCLARATION Nouvelle dclaration Dclaration modifie Le cas chant, indiquer la date de dpt de la dclaration modifie. (AAAA-MM-JJ) RUBRIQUE 2 - PARTIE ATTESTANT LA DCLARATION Indiquer la partie qui ...
Date: March 22, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement BROSSARD, Quebec, March 22, 2024 -- DIAGNOS Inc. (DIAGNOS or the Corporation) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces the closing of a second and final tranche of 650,000 units (each a Unit) issued at a...